日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lactulose, a Disaccharide Prebiotic, Improves the Gut-Kidney Axis via Enhancement of Akkermansia Muciniphila Production

乳果糖是一种双糖益生元,它通过增强阿克曼菌(Akkermansia Muciniphila)的产生来改善肠-肾轴功能。

Sueyoshi, Miyu; Watanabe, Hiroshi; Goto, Moritaka; Sato, Takao; Hashimoto, Mai; Oki, Mayu; Ofori-Attah, Ebenezer; Nakano, Takehiro; Maeda, Hitoshi; Tanaka, Motoko; Matsushita, Kazutaka; Jinnouchi, Hideaki; Maruyama, Toru; Kadowaki, Daisuke

Trends in sodium-glucose transport protein 2 inhibitor prescriptions: application of the ATC/DDD system to NDB open data

钠-葡萄糖协同转运蛋白2抑制剂处方趋势:ATC/DDD系统在NDB开放数据中的应用

Miyake, Takefumi; Hashimoto, Mai; Kadowaki, Daisuke

Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STING.

肠道微生物代谢产物丁酸盐通过增强感染性和激活 MHC-I/cGAS-STING 来提高表达 p53 的端粒酶特异性溶瘤腺病毒的功效。

Sakamoto Masaki, Kuroda Shinji, Katayama Tetsuya, Mikane Yu, Hanzawa Shunya, Kadowaki Daisuke, Yoshida Yusuke, Hamada Yuki, Sugimoto Ryoma, Yagi Chiaki, Hashimoto Masashi, Kanaya Nobuhiko, Kakiuchi Yoshihiko, Kikuchi Satoru, Shigeyasu Kunitoshi, Tazawa Hiroshi, Kagawa Shunsuke, Urata Yasuo, Fujiwara Toshiyoshi

Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapy.

血清细胞外囊泡中含有腺病毒 E1A-DNA,可作为溶瘤腺病毒治疗中液体活检的预测性生物标志物。

Yagi Chiaki, Kuroda Shinji, Kakiuchi Yoshihiko, Hanzawa Shunya, Kadowaki Daisuke, Yoshida Yusuke, Sakamoto Masaki, Hamada Yuki, Sugimoto Ryoma, Ohtani Tomoko, Kumon Kento, Hashimoto Masashi, Kanaya Nobuhiko, Kikuchi Satoru, Kagawa Shunsuke, Tazawa Hiroshi, Urata Yasuo, Fujiwara Toshiyoshi

Refinement of Replacement Fluid Using Human Serum Albumin Preparation to Enhance Biocompatibility in Therapeutic Plasma Exchange

利用人血清白蛋白制剂改进置换液以提高治疗性血浆置换的生物相容性

Narita, Yuki; Takegawa, Yoshitaka; Mizuta, Tomoyuki; Otsuka, Katsuji; Nakano, Hirotoshi; Kadowaki, Daisuke; Saito, Hideyuki; Adachi, Masataka

Author Correction: Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus

作者更正:表达 p53 的端粒酶特异性溶瘤腺病毒可长期激活胰腺癌中的抗肿瘤免疫

Hashimoto, Masashi; Kuroda, Shinji; Kanaya, Nobuhiko; Kadowaki, Daisuke; Yoshida, Yusuke; Sakamoto, Masaki; Hamada, Yuki; Sugimoto, Ryoma; Yagi, Chiaki; Ohtani, Tomoko; Kumon, Kento; Kakiuchi, Yoshihiko; Yasui, Kazuya; Kikuchi, Satoru; Yoshida, Ryuichi; Tazawa, Hiroshi; Kagawa, Shunsuke; Yagi, Takahito; Urata, Yasuo; Fujiwara, Toshiyoshi

Therapeutic Effect of Natural Products and Dietary Supplements on Aflatoxin-Induced Nephropathy

天然产物和膳食补充剂对黄曲霉毒素诱导肾病的治疗作用

Ofori-Attah, Ebenezer; Hashimoto, Mai; Oki, Mayu; Kadowaki, Daisuke

Correction to: Awareness and current implementation of drug dosage adjustment by pharmacists in patients with chronic kidney disease in Japan: a web-based survey

更正:日本药剂师对慢性肾病患者药物剂量调整的认知及当前实施情况:一项基于网络的调查

Kondo, Yuki; Ishitsuka, Yoichi; Shigemori, Eri; Irikura, Mitsuru; Kadowaki, Daisuke; Hirata, Sumio; Maemura, Takeshi; Irie, Tetsumi

In vivo evaluation of drug dialyzability in a rat model of hemodialysis

在血液透析大鼠模型中对药物透析可透析性的体内评价

Fukunaga, Masaki; Kadowaki, Daisuke; Mori, Mika; Hagiwara, Satomi; Narita, Yuki; Saruwatari, Junji; Tanaka, Ryota; Watanabe, Hiroshi; Yamasaki, Keishi; Taguchi, Kazuaki; Ito, Hiroki; Maruyama, Toru; Otagiri, Masaki; Hirata, Sumio

Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites

利用壳聚糖/环糊精复合材料设计及评价缓释奥美沙坦片

Anraku, Makoto; Tabuchi, Ryo; Goto, Miwa; Iohara, Daisuke; Mizukai, Yasuyuki; Maezaki, Yuji; Michihara, Akihiro; Kadowaki, Daisuke; Otagiri, Masaki; Hirayama, Fumitoshi